ADEOLA AJAYI, EKITI
Series of potential treatment now discover fit the treatment of Covid-19, University of Nebraska and the Texas Biomedical Research Institute have urged researchers to consider exploring the cannabis plant as a potential treatment regimen for COVID-19.
According to Harvard Medical School, even though medical marijuana, from the United States Government perspectives is illegal, it is legalised in 29 states, including the Washington, DC.
Marcel Bonn-Miller, PhD, a substance abuse specialist at the University of Pennsylvania Perelman School of Medicine, said the U.S. Drug Enforcement Administration, considers marijuana a Schedule I drug, the same as heroin, LSD, and ecstasy, and likely to be abused and lacking in medical value, adding “Because of that, researchers need a special license to study it.”
Despite no scientific evidence that cannabis or its compounds can specifically help with COVID-19, “Cytokines will normally help to create inflammation to fight off infections. But in these extreme cases, you see so much cytokines being released into the system that it creates a cytokine storm.
“You might see high fever, inflammation, severe fatigue and nausea, and in serious cases, it can lead to death through organ failure,” she said.
Earlenbaugh said the CBD extract is known from previous research as an IL-6 cytokine inhibitor, meaning it helps reduce the production of cytokines.
“They said CBD has shown beneficial anti-inflammatory effects in pre-clinical models of various chronic inflammatory diseases and that the U.S. Food and Drug Administration approved one CBD product to treat certain forms of epilepsy.
“CBD has very few side effects, so it’s something that’s being looked at as a much more mild treatment that still has a lot of anti-inflammatory powers,”